DM Pharma is actively involved in developing new formulations, conducting bioequivalence studies, clinical trials, and obtaining approvals from the Drug Controller General of India (DCGI) for the franchise and marketing of new Fixed Dose Combinations (FDCs) and molecules.
Through these efforts, we offer innovative formulations using DM Pharma’s proprietary technology, enabling our customers to market them under their own brand names.
DM Pharma manufactures innovative, technology-driven pharmaceutical products designed to meet evolving healthcare needs.
